iiinova — where your digital self keeps evolving

Tarek Aridi, MD

@tarekaridimd.bsky.social

119 followers 382 following 3 posts

PGY-3 IM Indiana University School of Medicine | Former T32-Postdoctoral Research Fellow BIDMC - Harvard Medical School | Aspiring Gastroenterologist/Hepatologist (he/him) #GISky #LiverSky #GastroSky

Posts Replies Media

Tarek Aridi, MD @tarekaridimd.bsky.social · 29/05/2025

🚨 Hot off the press! Our study is the first to define meaningful score differences (MSDs) for PROMIS, CLDQ & SF-36 in CLD - key to making PROMs clinically actionable! 🔗 journals.lww.com/hepcomm/Full... #LiverSky #GastroSky @aasldnews.bsky.social

011

Tarek Aridi, MD @tarekaridimd.bsky.social · 26/11/2024

Regarding TBWL%, Rapaka et al. found no significant difference between ESG (n=18) and IGB (n=23) at 3 and 6 months, with p-values of 0.97 and 0.41, respectively.

000

Tarek Aridi, MD @tarekaridimd.bsky.social · 25/11/2024

For anyone who missed #ACG2024! Intragastric Balloon (IGB) vs. Endoscopic Sleeve Gastroplasty (ESG) for weight loss 📍 ESG potentially achieves more durable weight loss with less side effects. 🔗 journals.lww.com/ajg/fulltext... #GISky #EndoscopySky #GastroSky @amcollegegastro.bsky.social

1100

Reposted by Tarek Aridi, MD

Gastroenterology @gastroenterology.bsky.social · 23/11/2024

#LiverSky: Performing early diagnostic paracentesis within 12 hours of admission may offer the greatest survival benefit. Share your thoughts on implementing this into practice! The American Journal of Gastroenterology #RedJournal @amcollegegastro.bsky.social 🔗 journals.lww.com/ajg/pages/ar...

0246